<?xml version="1.0" encoding="UTF-8"?>
<table xmlns="http://www.w3.org/1999/xhtml">
 <thead>
  <caption>PMC6072103</caption>
  <tr>
   <th>label</th>
   <th>caption</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td>Table 1</td>
   <td>Control strains.</td>
  </tr>
  <tr>
   <td>Table 2</td>
   <td>List of essential oils used in this study.</td>
  </tr>
  <tr>
   <td>Table 3</td>
   <td>Parameters used in GC/MS analysis of essential oils.</td>
  </tr>
  <tr>
   <td>Table 4</td>
   <td>Antimicrobial activities for selected EOs.</td>
  </tr>
  <tr>
   <td>Table 5</td>
   <td>Gas chromatography parameters for FAME analysis.</td>
  </tr>
  <tr>
   <td>Table 6</td>
   <td>Species and sequence type (ST) for Bcc clinical isolates.</td>
  </tr>
  <tr>
   <td>Table 7</td>
   <td>Antibiotic resistance of 51 Bcc clinical isolates. Number of ... </td>
  </tr>
  <tr>
   <td>Table 8</td>
   <td>MIC breakpoints (mg/l) used to assign susceptibility categor ... </td>
  </tr>
  <tr>
   <td>Table 9</td>
   <td>Number of clinical strains showing mean zones of inhibition ... </td>
  </tr>
  <tr>
   <td>Table 10</td>
   <td>Minimum inhibitory and bactericidal concentrations (% v/v) f ... </td>
  </tr>
 </tbody>
</table>
